Main > RHEUMATOLOGY>RHEUMATOID ARTHRITIS > Treatment > RituxiMAb (Approved) > Co.: USA. B (C20 MAb/Patents)
Co.: USA. B (C20 MAb/Patents)'s subsections
Company
Marketing>USA
Partner Company
Patent
Sales Value 2002: US$ 1.48 Billion
TradeMark
Web-Site
Co.: USA. B (C20 MAb/Patents)'s products
This section has no products